Figure 3. The Kaplan–Meier survival analysis of the primary HCC patients (n = 126) with high LZAP expression (n = 50) and low LZAP expression (n = 76) after surgical resection.

Based on their LZAP immunostaining scores, the HCC patients were divided into low-LZAP expression (LZAP− or LZAP+) and high-LZAP expression (LZAP++ or LZAP+++) groups. The survival rate of the patients in the low-LZAP group was significantly lower than that of the patients in the high-LZAP group (p = 0.008 for the log-rank test).